down arrow

Enanta Pharmaceuticals, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US29251M1062
USD
14.09
0.13 (0.93%)

Dec 04

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidated - Balance Sheet Results
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
Sep'19
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
0.00
0.00
0.00
0.00
0.00
0.00
Share Warrants & Outstandings
Total Reserve
128.81
216.74
321.33
399.43
455.58
462.49
Shareholder's Funds
128.81
216.74
321.33
399.43
455.58
462.49
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
Long-Term Borrowings
172.11
201.20
4.31
5.71
5.74
1.63
Secured Loans
172.11
201.20
4.31
5.71
5.74
1.63
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
0.00
0.00
0.00
0.00
-0.34
-11.34
Other Long Term Liabilities
68.33
29.46
28.01
3.75
9.57
4.31
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.00
0.00
0.00
0.56
1.08
2.00
Total Non-Current Liabilities
204.45
190.31
29.43
5.26
11.05
5.94
Current Liabilities
Trade Payables
8.00
4.10
6.00
9.54
5.74
6.69
Other Current Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
0.00
0.00
0.00
0.56
1.08
2.00
Total Current Liabilities
57.53
62.79
29.83
36.17
24.16
22.61
Total Liabilities
390.80
469.84
380.59
440.86
490.79
491.04
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
98.39
58.46
51.61
29.58
31.29
23.11
Less: Accumulated Depreciation
25.05
23.75
21.86
18.93
15.67
12.18
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
73.35
34.71
29.75
10.65
15.62
10.93
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
0.00
0.00
0.00
0.00
0.00
0.00
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
3.36
3.97
33.25
109.02
33.24
65.62
Long Term Loans & Advances
0.00
0.00
0.00
0.00
0.00
0.00
Other Non Current Assets
0.09
0.80
0.70
0.09
0.09
0.09
Total Non-Current Assets
90.95
47.05
68.88
121.84
53.95
89.19
Current Assets Loans & Advances
Current Investments
210.95
284.52
205.24
186.80
299.52
284.01
Inventories
0.00
0.00
0.00
0.00
0.00
0.00
Sundry Debtors
6.65
8.61
20.32
23.58
23.49
51.31
Cash and Bank
37.84
85.39
43.99
57.21
87.13
51.23
Other Current Assets
287.44
409.53
298.27
304.83
410.14
386.55
Short Term Loans and Advances
32.00
31.00
28.72
37.26
0.00
0.00
Total Current Assets
299.85
422.79
311.71
319.02
436.84
401.85
Net Current Assets (Including Current Investments)
242.32
360.00
281.89
282.85
412.68
379.24
Total Current Assets Excluding Current Investments
299.85
422.79
311.71
319.02
436.84
401.85
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
390.80
469.84
380.59
440.86
490.79
491.04
Contingent Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Total Debt
172.11
201.20
4.31
5.71
5.74
1.63
Book Value per share (adjusted)
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Sep 2024 is -15.37% vs 11,227.46% in Sep 2023

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Sep 2024 is 131.94% vs 5.18% in Sep 2023

stock-summary

Fixed Assets

YoY Growth in year ended Sep 2024 is 111.32% vs 16.67% in Sep 2023

stock-summary

Investments

YoY Growth in year ended Sep 2024 is -15.37% vs -88.06% in Sep 2023

stock-summary

Current Assets

YoY Growth in year ended Sep 2024 is -29.08% vs 35.64% in Sep 2023

Compare Balance Sheet Results of Enanta Pharmaceuticals, Inc.
Markets Mojo
Figures in Million
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
0
0
0.00
0.00%
Share Warrants & Outstandings
Total Reserve
128.81
53.90
74.91
138.98%
Shareholder's Funds
128.81
53.90
74.91
138.98%
Minority Interest
0
0
0.00
0.00%
Long-Term Borrowings
172.11
125.42
46.69
37.23%
Secured Loans
172.11
125.42
46.69
37.23%
Unsecured Loans
0
0
0.00
0.00%
Deferred Tax Assets / Liabilities
0
0.54
-0.54
-100.00%
Other Long Term Liabilities
68.33
60.42
7.91
13.09%
Long Term Trade Payables
0
0
0.00
0.00%
Long Term Provisions
0
0
0.00
0.00%
Total Non-Current Liabilities
204.45
180.93
23.52
13.00%
Current Liabilities
Trade Payables
8.00
16.33
-8.33
-51.01%
Other Current Liabilities
0
0
0.00
0.00%
Short Term Borrowings
0
0
0.00
0.00%
Short Term Provisions
0
0
0.00
0.00%
Total Current Liabilities
57.53
38.87
18.66
48.01%
Total Liabilities
390.80
273.70
117.10
42.78%
ASSETS
Non-Current Assets
0
0
0.00
0.00%
Gross Block
98.39
201.37
-102.98
-51.14%
Less: Accumulated Depreciation
25.05
50.33
-25.28
-50.23%
Less : Impairment of Assets
0
0
0.00
0.00%
Net Block
73.35
151.04
-77.69
-51.44%
Lease Adjustment
0
0
0.00
0.00%
Capital Work in Progress
0
0
0.00
0.00%
Intangible assets under development
0
0
0.00
0.00%
Pre-operative Expenses pending
0
0
0.00
0.00%
Assets in transit
0
0
0.00
0.00%
Non Current Investments
3.36
0
3.36
0.00%
Long Term Loans & Advances
0
0
0.00
0.00%
Other Non Current Assets
0.09
3.81
-3.72
-97.64%
Total Non-Current Assets
90.95
192.67
-101.72
-52.79%
Current Assets Loans & Advances
Current Investments
210.95
0
210.95
0.00%
Inventories
0
39.98
-39.98
-100.00%
Sundry Debtors
6.65
31.15
-24.50
-78.65%
Cash and Bank
37.84
8.46
29.38
347.28%
Other Current Assets
287.44
79.59
207.85
261.15%
Short Term Loans and Advances
32.00
0
32.00
0.00%
Total Current Assets
299.85
81.03
218.82
270.05%
Net Current Assets (Including Current Investments)
242.32
42.16
200.16
474.76%
Total Current Assets Excluding Current Investments
299.85
81.03
218.82
270.05%
Miscellaneous Expenses not written off
0
0
0.00
0.00%
Total Assets
390.80
273.70
117.10
42.78%
Contingent Liabilities
0
0
0.00
0.00%
Total Debt
172.11
125.42
46.69
37.23%
Book Value per share (adjusted)
0
0
0.00
0.00%
Annual - Borrowings
Borrowings 136.13 Million
in Sep 2024

Figures in Million
stock-summary

YoY Growth in year ended Sep 2024 is -15.37% vs 11,227.46% in Sep 2023

Annual - Other Long Term Liabilities
Other Long Term Liabilities 68.33 Million
in Sep 2024

Figures in Million
stock-summary

YoY Growth in year ended Sep 2024 is 131.94% vs 5.18% in Sep 2023

Annual - Fixed Assets
Fixed Assets 73.35 Million
in Sep 2024

Figures in Million
stock-summary

YoY Growth in year ended Sep 2024 is 111.32% vs 16.67% in Sep 2023

Annual - Investments
Investments 3.36 Million
in Sep 2024

Figures in Million
stock-summary

YoY Growth in year ended Sep 2024 is -15.37% vs -88.06% in Sep 2023

Annual - Current Assets
Current Assets 299.85 Million
in Sep 2024

Figures in Million
stock-summary

YoY Growth in year ended Sep 2024 is -29.08% vs 35.64% in Sep 2023

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."